Rechtsherzinsuffizienz

Klinische Evidenz

RECOVER RIGHT: Sicherheit und Wirksamkeit

73 % Überlebensrate nach 30 Tagen1

 

Ergebnisse der NCSI-Studie zur rechtsventrikulären Dysfunktion

References

  1. Anderson M.B., et al. (2015). J Heart Lung Transplant. 34(12), 1549-1560.

NPS-1326

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].